Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer

Published:2017-08 Issue:1-2 Volume:528 Page:322-333
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Feng Chunlai,Rui Mengjie,Shen Haijun,Xin Yuanrong,Zhang Jie,Li Jun,Yue Lixiang,Lai Wenlong,Xu Ximing

Funder

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province for Youth

Jiangsu Province Postdoctoral Science Foundation

Scientific Research Foundation of Jiangsu Universit

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference45 articles.

1. Triggered pH/redox responsive release of doxorubicin from prepared highly stable graphene with thiol grafted Pluronic;Al-Nahain;Int. J. Pharm.,2013

2. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231;Aroui;Cancer Lett.,2009

3. Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study;Aroui;Biochem. Biophys. Res. Commun.,2010

4. Activable cell-penetrating peptide conjugated prodrug for tumor targeted drug delivery;Cheng;ACS Appl. Mater. Interfaces,2015

5. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery;Danhier;J. Control. Release,2010

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paclitaxel for breast cancer therapy: A review on effective drug combination modalities and nano drug delivery platforms;Journal of Drug Delivery Science and Technology;2024-05

2. New Transferrin Receptor-Targeted Peptide–Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity;Molecules;2024-04-12

3. Doxorubicin conjugates: a practical approach for its cardiotoxicity alleviation;Expert Opinion on Drug Delivery;2024-03-03

4. Aptamer-based Theranostics in Oncology: Design Strategies and Limitations;BIO Integration;2024

5. Maltotriose acylhydrazone surfactants: Structure-property profiles and efficient in vivo drug delivery for primary biliary cholangitis treatment;Journal of Molecular Liquids;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3